SCHEMBL13630780

SCHEMBL13630780

CCOC(=O)CC(C1CCCC1)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.47
THRB P10828 1/20 0.47
ATM Q13315 1/20 0.47
HPGD P15428 2/20 0.46
DPP4 P27487 1/20 0.43
CYP2D6 P10635 1/20 0.42
ALDH1A1 P00352 3/20 0.42
RECQL P46063 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
GPR119 Q8TDV5 2/20 0.41
EED O75530 1/20 0.41
RBBP4 Q09028 1/20 0.41
SUZ12 Q15022 1/20 0.41
EZH2 Q15910 1/20 0.41
AEBP2 Q6ZN18 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2939689 0.85 EPHX1 (0.53) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL2945143 0.85 EPHX1 (0.53) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL2944912 0.84 EPHX1 (0.52) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL4417481 0.84 EED (0.45) EPHX1HPGDDPP4ALDH1A1RECQL
SCHEMBL1575174 0.84 GPR119 (0.50) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL19554688 0.84 GPR119 (0.50) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL2940070 0.84 DPP4 (0.40) EPHX1L3MBTL1HPGDDPP4ALDH1A1
SCHEMBL12082901 0.83 DPP4 (0.55) EPHX1HPGDDPP4ALDH1A1RECQL
SCHEMBL13515440 0.81 EPHX1 (0.55) EPHX1L3MBTL1THRBATMHPGD
SCHEMBL13316244 0.81 DPP4 (0.42) EPHX1HPGDDPP4ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 US disclosed
US-7618987-B2 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK & CO., INC. (US) 2009-11-17 US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 US disclosed
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MERCK SHARP & DOHME CORP. 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191433-A1 Acylated piperidine derivatives as melanocortin 4-receptor agonists MC4R, MC5R, MC3R EPHX1 3891/4885L3MBTL1 2918/4885THRB 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.